These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26017713)

  • 1. Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.
    El-Hajj S; AlJaroudi WA; Farag A; Bleich S; Manaoragada P; Iskandrian AE; Hage FG
    J Nucl Cardiol; 2016 Feb; 23(1):101-12. PubMed ID: 26017713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of regadenoson myocardial perfusion imaging.
    Hage FG; Ghimire G; Lester D; Mckay J; Bleich S; El-Hajj S; Iskandrian AE
    J Nucl Cardiol; 2015 Dec; 22(6):1214-21. PubMed ID: 25677160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging.
    Lester D; El-Hajj S; Farag AA; Bhambhvani P; Tauxe L; Heo J; Iskandrian AE; Hage FG
    J Nucl Cardiol; 2016 Oct; 23(5):1147-1155. PubMed ID: 26490267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.
    Doukky R; Fughhi I; Campagnoli T; Wassouf M; Ali A
    J Nucl Cardiol; 2017 Feb; 24(1):112-118. PubMed ID: 26582040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging.
    Farzaneh-Far A; Shaw LK; Dunning A; Oldan JD; O'Connor CM; Borges-Neto S
    J Nucl Cardiol; 2015 Aug; 22(4):600-7. PubMed ID: 25987234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers.
    Gowdar S; Ahlberg AW; Rai M; Perucki WH; Felpel KD; Savino JA; Alter EL; Henzlova MJ; Duvall WL
    J Nucl Cardiol; 2020 Dec; 27(6):2320-2331. PubMed ID: 30815834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.
    Mahmarian JJ; Peterson LE; Xu J; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Nabi F
    J Nucl Cardiol; 2015 Apr; 22(2):248-61. PubMed ID: 25287737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.
    Hage FG; Dean P; Iqbal F; Heo J; Iskandrian AE
    J Nucl Cardiol; 2011 Dec; 18(6):1086-94. PubMed ID: 21785922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.
    AlJaroudi W; Campagnoli T; Fughhi I; Wassouf M; Ali A; Doukky R
    J Nucl Cardiol; 2016 Jun; 23(3):560-9. PubMed ID: 26293358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.
    Iqbal FM; Hage FG; Ahmed A; Dean PJ; Raslan S; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.
    Freed BH; Narang A; Bhave NM; Czobor P; Mor-Avi V; Zaran ER; Turner KM; Cavanaugh KP; Chandra S; Tanaka SM; Davidson MH; Lang RM; Patel AR
    J Cardiovasc Magn Reson; 2013 Dec; 15(1):108. PubMed ID: 24359617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.
    Andrikopoulou E; AlJaroudi WA; Farag A; Lester D; Patel H; Iskandrian AE; Hage FG
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1493-502. PubMed ID: 27079736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic and prognostic value of near-normal perfusion or borderline ischemia on stress myocardial perfusion imaging.
    Kassab K; Hussain K; Torres A; Iskander F; Iskander M; Khan R; Doukky R
    J Nucl Cardiol; 2022 Apr; 29(2):826-835. PubMed ID: 33034835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine triphosphate stress myocardial perfusion imaging for risk stratification of patients aged 70 years and older with suspected coronary artery disease.
    Yao Z; Zhu H; Li W; Chen C; Wang H; Shi L; Zhang W
    J Nucl Cardiol; 2017 Apr; 24(2):429-433. PubMed ID: 26797919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging.
    Gomez J; Golzar Y; Fughhi I; Olusanya A; Doukky R
    J Nucl Cardiol; 2018 Aug; 25(4):1313-1323. PubMed ID: 28181156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic significance of ischemic electrocardiographic changes with regadenoson-stress myocardial perfusion imaging.
    Doukky R; Olusanya A; Vashistha R; Saini A; Fughhi I; Mansour K; Nigatu A; Confer K; Sims SA
    J Nucl Cardiol; 2015 Aug; 22(4):700-13. PubMed ID: 25907352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol.
    Thomas GS; Cullom SJ; Kitt TM; Feaheny KM; Ananthasubramaniam K; Gropler RJ; Jain D; Thompson RC
    J Nucl Cardiol; 2017 Jun; 24(3):788-802. PubMed ID: 28224449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of mechanical left ventricular dyssynchrony defined by phase analysis from gated single-photon emission computed tomography myocardial perfusion imaging among patients with coronary heart disease.
    Hess PL; Shaw LK; Fudim M; Iskandrian AE; Borges-Neto S
    J Nucl Cardiol; 2017 Apr; 24(2):482-490. PubMed ID: 26809439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
    Mahmarian JJ; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Hendel RC; Moye LA; Olmsted AW
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):959-68. PubMed ID: 19679284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of absent left ventricular ejection fraction reserve with regadenoson SPECT MPI.
    Smith P; Farag A; Bhambhvani P; Iskandrian A; Hage FG
    J Nucl Cardiol; 2022 Jun; 29(3):978-986. PubMed ID: 33089878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.